前交叉韧带重建术后建立临床 distinct 患者治疗亚组:机器学习聚类分析
基于1990至2016年纵向人群登记数据,纳入923例前交叉韧带损伤患者(785例重建,138例非手术),随访至少7.5年。无监督随机森林识别出两个亚组:最佳结局组653例,次佳结局组270例;次佳组继发性半月板损伤、症状性创伤后骨关节炎及进展至全膝关节置换率显著更高(均P<.01)。重建在最佳组对继发性半月板损伤(ATE 61%)、对侧前交叉韧带损伤(ATE 8%)、症状性创伤后骨关节炎(ATE 16%)及进展至全膝关节置换(ATE 6%)均有显著保护作用(均P<.01);在次佳组仅对症状性创伤后骨关节炎(ATE 11%)和进展至全膝关节置换(ATE 8%)有保护作用(均P<.01)。
要点
- 两个临床有意义亚组:最佳结局组653例,次佳结局组270例,后者继发性半月板损伤、症状性创伤后骨关节炎及全膝关节置换率更高(均P<.01)。
- 最佳组重建对继发性半月板损伤ATE 61%、对侧前交叉韧带损伤ATE 8%、症状性创伤后骨关节炎ATE 16%、全膝关节置换ATE 6%均有显著保护(均P<.01)。
- 次佳组重建仅对症状性创伤后骨关节炎ATE 11%和全膝关节置换ATE 8%有保护(均P<.01)。
核心结论
- 从回顾性收集数据中识别出两个临床有意义亚组,前交叉韧带损伤后治疗反应存在差异。
- 重建在两个亚组均降低创伤后骨关节炎和全膝关节置换发生率,但在年龄较大、体重较重或合并内侧半月板损伤患者中预防继发性半月板损伤或对侧前交叉韧带损伤的效果较差。
研究设计与样本
- 队列研究,证据等级3级。
- 纵向人群登记识别1990至2016年前交叉韧带损伤患者,最低随访7.5年。
- 采用无监督随机森林算法建立并验证患者亚组,使用机器学习因果推断估计器分析重建的治疗效应,并将亚组归属纳入多变量逻辑回归识别预测最佳结局的因素。
主要发现
- 共纳入923例患者(785例初次重建,138例非手术)。
- 随机森林算法得出2个亚组的最优划分:最佳结局亚组653例(男性368例[56.4%],平均年龄26.0±10.2岁,平均体重指数26.5±4.30),次佳结局亚组270例(男性152例[56.3%],平均年龄35.0±10.1岁,平均体重指数30.5±5.54)。
- 次佳结局亚组在最终随访时继发性半月板损伤、症状性创伤后骨关节炎发生及进展至全膝关节置换的比率显著增高(均P<.01)。
- 最佳结局亚组中,重建对继发性半月板损伤(平均治疗效应61%)、对侧前交叉韧带损伤(平均治疗效应8%)、症状性创伤后骨关节炎(平均治疗效应16%)及进展至全膝关节置换(平均治疗效应6%)有显著保护治疗效应(均P<.01)。
- 次佳结局亚组中,重建仅对症状性创伤后骨关节炎(平均治疗效应11%)和进展至全膝关节置换(平均治疗效应8%)有保护作用(均P<.01)。
局限性
- 两个临床有意义亚组是从回顾性收集数据中识别的。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Treatment decisions in patients with anterior cruciate ligament (ACL) injuries are influenced by multiple factors, such as the desire to return to sports or symptomatic instability. Identifying the differential treatment effect of ACL reconstruction (ACLR) compared with nonoperative management on a patient-specific level can inform surgical decision-making. HYPOTHESIS: Unsupervised machine learning can identify distinct patient subgroups based on outcome achievement after ACL injury, and ACLR will exert a protective effect on the development of posttraumatic osteoarthritis (PTOA) over nonoperative management. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: A longitudinal populational registry identified patients with ACL injuries from 1990 to 2016 with a minimum 7.5-year follow-up. An unsupervised random forest algorithm was utilized to develop and validate patient subgroups. Treatment effects of ACLR on outcomes were analyzed using a machine learning causal inference estimator. Patient subgroup membership was incorporated into a multivariable logistic regression to identify factors predictive of optimal outcomes. RESULTS: A total of 923 patients (785 primary ACLR, 138 nonoperative) were included. The random forest algorithm arrived at an optimal partition of 2 subgroups, with 653 patients in the optimal outcome subgroup (368 male [56.4%]; mean age, 26.0 ± 10.2 years; mean body mass index [BMI], 26.5 ± 4.30) and 270 patients in the suboptimal outcome subgroup (152 male [56.3%]; mean age, 35.0 ± 10.1 years; mean BMI, 30.5 ± 5.54). The latter group demonstrated significantly increased rates of secondary meniscal injury, development of symptomatic PTOA, and progression to total knee arthroplasty (TKA) at the final follow-up (all P < .01). In the optimal outcome subgroup, ACLR had significantly protective treatment effects on the risk of secondary meniscal injury (average treatment effect [ATE], 61%), contralateral ACL injury (ATE, 8%), symptomatic PTOA (ATE, 16%), and progression to TKA (ATE, 6%) (all P < .01). Conversely, in the suboptimal outcome subgroup, ACLR only protected against symptomatic PTOA (ATE, 11%) and progression to TKA (ATE, 8%) (both P < .01). CONCLUSION: Two clinically meaningful subgroups were identified from retrospectively collected data and found to experience differential treatment responses after ACL injuries. ACLR decreased the rate of development of PTOA and TKA in both subgroups but was not as effective in preventing secondary meniscal injuries or contralateral ACL injuries in patients who were older, heavier, or had concomitant medial meniscus injuries.
引用
- Lu Y, Kang L, Mavrommatis S, et al. Establishing Clinically Distinct Patient Treatment Subgroups Following Anterior Cruciate Ligament Reconstruction: A Machine Learning Clustering Analysis. Am J Sports Med. 2025. PMID: 40815848. doi:10.1177/03635465251360240
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。